Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sichuan Huiyu Pharmaceutical Co., Ltd
Jonsson Comprehensive Cancer Center
University of Illinois at Chicago
Harbin Medical University
University Health Network, Toronto
The University of Hong Kong
Shandong Cancer Hospital and Institute
University of Michigan Rogel Cancer Center
Sohag University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Endeavor Health
Zhongnan Hospital
Masonic Cancer Center, University of Minnesota
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The First Affiliated Hospital with Nanjing Medical University
Albert Einstein College of Medicine
Indiana University
Huazhong University of Science and Technology
Peking University Cancer Hospital & Institute
New Mexico Cancer Research Alliance
Indiana University
ChineseAMS
Tianjin Medical University Cancer Institute and Hospital
Fudan University
Swedish Red Cross University College
AVEO Pharmaceuticals, Inc.
China Medical University, China
Academic and Community Cancer Research United
Masonic Cancer Center, University of Minnesota
Peking Union Medical College
Zhejiang Cancer Hospital
Mercator MedSystems, Inc.
University of Michigan Rogel Cancer Center
Instituto do Cancer do Estado de São Paulo
University of Chicago
Memorial Sloan Kettering Cancer Center
University of Miami
Campus Bio-Medico University
National Cancer Institute (NCI)
Taizhou Hospital
SCRI Development Innovations, LLC
National Institutes of Health Clinical Center (CC)
King Faisal Specialist Hospital & Research Center